ClinTex (CLX) ICO Details & Financial Information

More Info About ICO

ICO NameClinTex
SymbolCLX
Start DateOctober 01, 2018
End DateNovember 05, 2018
CountryMalta
PlatformEthereum
Show All

ClinTex is a clinical trials collaboration and data analytics platform that leverages the benefits of distributed ledger technology (blockchain). It uses smart contracts on the Ethereum public blockchain to provide an end to end decentralised solution that incorporates tools to drive collaboration in the sharing of clinical trial data across the industry and significant quality and operational improvements in running clinical trials through advanced clinical data review, insightful operational key performance indicators (KPIs), predictive data analytics and machine learning (AI). The ClinTex Clinical Trials Intelligence Platform (ClinTex CTi) will vastly improve pharmaceutical companies’ operational and clinical effectiveness in setting-up, conducting, overseeing, reviewing, and meeting regulatory standards for clinical trials.

Director of Clinical Data Services
Director of Operations
Medical Officer

CLX Token Sale scheduled for Q2 2019
https://t.co/Fc7LaRM1nN

They are ICOGenius, a group of passionate #cryptocurrency #traders, #investors and reviewers. They dedicate their time to look into #ICO and decide if they are worth investing in. And here is #Clintex Review - https://t.co/Xgjp8BAkUw

Read new interview with Neil Barron - Director of Clinical Data Analytics at ClinTex:
https://t.co/VH5MpiwevI

Watch new #Review about #Clintex from independent team - Bitcoin Xchange! Like, share and leave your comments, we appreciate your feedback a lot!
https://t.co/9RMRkXFxgO

Load More...
Price1 CLX = 0.10 USD SaleN/A Payment ModeBTC, ETH
Minimum InvestmentN/A Distribution50% RaisedN/A
Soft Cap4,000,000 USD Hard Cap19,000,000 USD

Comments

We would like to keep you updated with special notifications.

x

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

I accept I decline